Kaya Holdings (KAYS) Shares Outstanding (Diluted Average) (2017 - 2025)

Kaya Holdings (KAYS) recorded quarterly Shares Outstanding (Diluted Average) of $78.1 million in Q3 2025, up 83.05% quarter-over-quarter from $42.7 million in Q2 2025, and up 221.03% on a YoY basis from $24.3 million in Q3 2024.

Kaya Holdings (KAYS) Shares Outstanding (Diluted Average) (2017 - 2025) Analysis & Trends

Kaya Holdings' Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $78.1 million for Q3 2025.

  • In Q3 2025, Shares Outstanding (Diluted Average) rose 221.03% year-over-year to $78.1 million; the TTM figure through Sep 2025 stood at $78.1 million (up 221.03% YoY), while the FY2024 annual figure was $257.7 million, up 26.49% from the prior year.
  • Shares Outstanding (Diluted Average) was $78.1 million for Q3 2025 at Kaya Holdings, up from $42.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $257.7 million in Q4 2024 to a low of $14.3 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $90.2 million across 5 years, with a median of $70.2 million in 2021.
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) soared 1283.91% in 2023, then plunged 83.07% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $72.2 million in 2021, then slumped by 79.15% to $15.0 million in 2022, then surged by 1253.82% to $203.7 million in 2023, then increased by 26.49% to $257.7 million in 2024, then tumbled by 69.7% to $78.1 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $78.1 million (Q3 2025), $42.7 million (Q2 2025), and $42.7 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Kaya Holdings - - 5,370.00 78.10 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 78.10 Mn
Jun 30, 2025 42.66 Mn
Mar 31, 2025 42.67 Mn
Dec 31, 2024 257.72 Mn
Sep 30, 2024 24.33 Mn
Jun 30, 2024 221.97 Mn
Mar 31, 2024 185.80 Mn
Dec 31, 2023 203.74 Mn
Sep 30, 2023 143.72 Mn
Jun 30, 2023 22.17 Mn
Mar 31, 2023 203.75 Mn
Dec 31, 2022 15.05 Mn
Sep 30, 2022 14.72 Mn
Jun 30, 2022 14.72 Mn
Mar 31, 2022 14.72 Mn
Dec 31, 2021 72.18 Mn
Sep 30, 2021 71.03 Mn
Jun 30, 2021 70.17 Mn
Mar 31, 2021 14.33 Mn
Dec 31, 2020 13.16 Mn